V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10388815 | 10064789 | 1.66 | 84.9 | null | 2017-12-24 | 2017-12-24 | Bortezomib (weekly) | 02 | null | BORTEZOMIB | 101530889 |
| 10388828 | 10064790 | 1.8 | 65.4 | null | 2019-06-23 | 2019-06-28 | CABOZANTINIB | 02 | null | ACALABRUTINIB | 100260280 |
| 10388834 | 10064791 | null | 93 | 03 | null | 2017-12-23 | Carboplatin + Liposomal Doxorubicin | 02 | N | CISPLATIN | 101773311 |
| 10389303 | 10064792 | 1.58 | 93.2 | null | 2019-01-31 | 2019-03-02 | CVP R | 02 | null | PERTUZUMAB + TRASTUZUMAB | 101789811 |
| 10389602 | 10064794 | 1.75 | 103 | Curative (C) | 2019-05-04 | 2019-05-13 | Bortezomib +/- Dexamethasone | 02 | N | BORTEZOMIB | 100083982 |
| 10390012 | 10064796 | 1.81 | 63 | 03 | 2019-07-26 | 2019-07-26 | Trifluridine + Tipiracil | 02 | N | TIPIRACIL + TRIFLURIDINE | 101020563 |
| 10390065 | 10064797 | 1.88 | 65 | Palliative (P) | 2019-12-20 | 2020-01-17 | Capecitabine (14 day) + Irinotecan | 02 | N | NIRAPARIB | 101295404 |
| 10390163 | 10064798 | 1.81 | 75.4 | null | 2019-02-03 | 2019-02-03 | IPILIMUMAB + NIVOLUMAB | 02 | null | VINORELBINE | 100682907 |
| 10390166 | 10064799 | 1.68 | 64.9 | Palliative (P) | 2020-01-14 | 2020-06-02 | Vinorelbine IV | N | N | CISPLATIN + GEMCITABINE | 100576185 |
| 10390535 | 10064800 | 1.79 | 88.6 | Adjuvant (A) | 2020-11-13 | 2020-12-04 | BUSULFAN | 02 | null | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 100994518 |
| 10390565 | 10064802 | 1.68 | 88.25 | Palliative (P) | 2018-02-17 | 2018-06-20 | BENDAMUSTINE + POLATUZUMAB VEDOTIN + RITUXIMAB | 02 | null | CETUXIMAB | 100055524 |
| 10390747 | 10064804 | 1.58 | null | null | 2018-09-30 | 2018-12-27 | Bortezomib (weekly) | 02 | null | BORTEZOMIB | 101002853 |
| 10391784 | 10064809 | 1.76 | 84.9 | null | 2020-08-21 | 2020-08-21 | Bortezomib + Panobinostat | 02 | null | BORTEZOMIB + PANOBINOSTAT | 100995757 |
| 10392325 | 10064813 | null | 70 | Adjuvant (A) | 2022-02-21 | 2022-03-15 | Bortezomib + Cyclophos + Dex | 02 | N | BORTEZOMIB + CYCLOPHOSPHAMIDE | 100748911 |
| 10392347 | 10064814 | 1.62 | 46 | Palliative (P) | 2017-08-19 | 2017-11-18 | Bortezomib (weekly) | 02 | N | BORTEZOMIB | 101734816 |
| 10392600 | 10064816 | 1.39 | 75.8 | null | 2020-01-28 | 2020-02-12 | Azacitidine | 02 | null | AZACITIDINE | 100781718 |
| 10392729 | 10064818 | 1.57 | 72.8 | Palliative (P) | 2018-09-26 | 2018-11-02 | Azacitidine | 02 | N | AZACITIDINE | 100025261 |
| 10392926 | 10064819 | 0 | 83 | Palliative (P) | 2020-06-19 | 2020-09-13 | CARBOPLATIN + VINORELBINE | 02 | N | CARBOPLATIN + VINORELBINE | 100659922 |
| 10392961 | 10064820 | 1.87 | 59.8 | null | 2019-12-14 | 2019-12-21 | Cabazitaxel | 02 | null | CABAZITAXEL | 101666642 |
| 10393729 | 10064822 | 1.74 | 84.2 | Neo-adjuvant (N) | 2018-09-14 | 2018-09-22 | CVP R | 02 | N | DABRAFENIB | 101140195 |
| 10393798 | 10064823 | 1.79 | 83.6 | null | 2020-10-31 | 2021-02-04 | Cabazitaxel | 02 | null | CABAZITAXEL | 100784295 |
| 10393881 | 10064824 | 1.5 | null | Palliative (P) | 2018-10-30 | 2018-11-03 | FLUOROURACIL | 02 | N | PERTUZUMAB + TRASTUZUMAB | 101109475 |
| 10393924 | 10064825 | 1.68 | 56 | 03 | 2019-08-28 | 2019-08-28 | CETUXIMAB | 02 | N | ACALABRUTINIB | 100544328 |
| 10393926 | 10064826 | 1.82 | 88.4 | null | 2017-03-26 | 2017-03-26 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | null | GEMCITABINE | 101412472 |
| 10394017 | 10064827 | 1.78 | 73.4 | Palliative (P) | 2020-03-14 | 2020-03-21 | Bortezomib + Cyclophos + Dex | 02 | N | BORTEZOMIB + CYCLOPHOSPHAMIDE | 100469794 |
| 10394052 | 10064828 | 1.78 | null | null | 2018-02-08 | 2018-02-18 | BUSULFAN | null | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101138085 |
| 10394078 | 10064829 | 1.79 | 82 | Curative (C) | 2019-04-02 | 2019-04-22 | Methotrexate intrathecal | 02 | N | METHOTREXATE | 100787896 |
| 10394092 | 10064830 | 1.7 | 48 | null | 2020-12-27 | 2020-12-29 | DABRAFENIB + TRAMETINIB | 02 | null | DABRAFENIB + TRAMETINIB | 101218214 |
| 10394095 | 10064831 | 0 | 59.8 | Palliative (P) | 2019-12-26 | 2019-12-26 | Fluorouricil + Folonic Acid (MdG) | 2 | N | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 101313413 |
| 10394305 | 10064834 | 1.66 | 64.9 | null | 2022-03-12 | 2022-04-02 | Chlorambucil | 02 | null | CHLORAMBUCIL | 100722742 |
| 10394438 | 10064836 | 1.74 | 121.2 | Adjuvant (A) | 2017-08-21 | 2017-10-07 | PERTUZUMAB + TRASTUZUMAB | 02 | N | PERTUZUMAB + TRASTUZUMAB | 101616712 |
| 10394516 | 10064837 | 1.62 | 89.4 | Palliative (P) | 2019-11-28 | 2019-12-05 | Azacitidine | 02 | N | AZACITIDINE | 101465613 |
| 10394555 | 10064838 | 1.56 | 53.5 | 03 | 2017-07-16 | 2019-02-13 | CETUXIMAB + IRINOTECAN + MDG | N | N | CABOZANTINIB | 101766674 |
| 10394712 | 10064839 | 1.72 | 63.5 | null | null | 2018-02-09 | PEMBROLIZUMAB + PEMETREXED | 02 | null | CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED | 101013147 |
| 10394802 | 10064840 | null | null | null | 2019-06-28 | 2019-07-02 | ECarboX | 02 | null | AML18 TRIAL | 100768299 |
| 10395191 | 10064842 | 1.63 | 0 | Disease modification (D) | 2020-08-16 | 2020-08-26 | CAPECITABINE + TEMOZOLOMIDE | 02 | null | RUCAPARIB | 100242839 |
| 10395391 | 10064843 | 1.82 | 46 | null | 2019-06-24 | 2020-07-14 | Eribulin | null | null | BENDAMUSTINE | 100933024 |
| 10395783 | 10064844 | null | 71.1 | null | 2016-12-23 | 2017-05-17 | CCEP | 99 | null | CYTARABINE + DAUNORUBICIN | 100563493 |
| 10396318 | 10064847 | 1.57 | 0 | 03 | 2019-11-28 | 2019-11-28 | Cyclophosphamide + Etoposide (PO) | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL | 100462041 |
| 10396943 | 10064848 | 1.48 | 81.15 | null | null | 2018-05-18 | CTD | null | null | SOTORASIB | 101240498 |
| 10397323 | 10064849 | 1.74 | 64.4 | null | 2017-01-31 | 2017-03-05 | AXITINIB | 02 | null | ISATUXIMAB + POMALIDOMIDE | 101420043 |
| 10397367 | 10064850 | 1.48 | 93.5 | null | 2017-02-16 | 2017-02-22 | Raltitrexed | 02 | null | CYCLOPHOSPHAMIDE + ETOPOSIDE + PROCARBAZINE | 101497066 |
| 10397511 | 10064851 | null | null | null | 2017-08-01 | 2018-03-17 | Carboplatin + Cetux + FU (>Cycle 2) | null | null | EVEROLIMUS | 100559080 |
| 10397590 | 10064852 | null | null | Curative (C) | 2017-04-06 | 2017-10-29 | Cytarabine Low Dose | 02 | N | TRANSPLANT CYCLOPHOSPHAMIDE + FLUDARABINE + TREOSULFAN | 100093561 |
| 10397618 | 10064853 | 1.75 | 93.3 | null | 2019-06-07 | 2019-06-29 | IPILIMUMAB + PEMBROLIZUMAB | 02 | null | LENVATINIB | 101547259 |
| 10397620 | 10064854 | 1.64 | 71 | null | 2017-10-23 | 2018-08-29 | EVEROLIMUS | null | null | DOXORUBICIN | 100064934 |
| 10398434 | 10064855 | null | null | Palliative (P) | 2018-02-03 | 2018-02-18 | Irinotecan + Modified De Gramont | N | N | CYCLOPHOSPHAMIDE + LENALIDOMIDE | 101642594 |
| 10398606 | 10064856 | 0 | 60.6 | Palliative (P) | 2018-02-23 | 2018-02-24 | Binimetinib + Encorafenib | 02 | N | PEMETREXED | 101834453 |
| 10398750 | 10064857 | 1.6 | 61.8 | null | 2018-10-01 | 2018-10-01 | CISPLATIN + GEMCITABINE + RITUXIMAB | Y | null | NERATINIB | 100784661 |
| 10398787 | 10064858 | 1.63 | 56.7 | 03 | 2018-01-12 | 2018-01-12 | CARDAMON trial | 02 | N | ERIBULIN | 101025961 |